Table 3.
Recipient demographics and clinical outcomes of transplanted livers.
| Recipient Characteristics | Overall Cohort (n = 29) |
DBD (n = 22) |
DCD (n = 7) |
p Value |
|---|---|---|---|---|
| Age [y, median (IQR)] |
60 (50–68) |
62 (47–70) |
60 (56–63) |
0.5909 |
| Sex ratio [n (%)] | ||||
| Male | 18 (62.1%) | 14 (63.6%) | 4 (57.1%) | |
| Female | 11 (37.9%) | 8 (36.4%) | 3 (42.9%) | >0.9999 |
| BMI [kg/m2, median (IQR)] |
25.8 (20.9–29.6) |
24.7 (20.6–29.7) |
26.2 (23.8–28.6) |
0.9901 |
| MELD [median (IQR)] |
12.0 (7.5–19.8) |
12.0 (10.0–25.0) |
12.0 (6.0–18.5) |
0.2008 |
| Clinical outcome | ||||
| L-GrAFT [median (IQR)] |
−0.994 (−1.351–0.174) |
−1.022 (−1.383–0.040) |
−0.516 (−1.416–0.174) |
0.6999 |
| MEAF [median (IQR)] |
4.835 (4.070–6.700) |
4.905 (4.178–6.615) |
4.680 (3.478–6.903) |
0.7897 |
| EAD | 10 (34.5%) | 8 (36.4%) | 2 (28.6 %) | 0.3298 |
| 1-year patient survival | 25 (86.2%) | 20 (90.9%) | 5 (71.4%) | 0.1930 |
| 1-year graft survival | 25 (86.2%) | 20 (90.9%) | 5 (71.4%) | 0.1930 |
DBD, donation after brain death; DCD, donation after circulatory death; y, years; IQR, interquartile range; BMI, body mass index; MELD, a model for end-stage liver disease; L-GrAFT, liver graft assessment following transplantation; MEAF, model for early allograft function; EAD, early allograft dysfunction.